Our portfolio company, BC platforms announced an expanded partnership with Bumrungrad International Hospital (Bangkok, Thailand), one of the largest private hospitals in Southeast Asia and a world leader in healthcare delivery and pioneering clinical research.
Bumrungrad will now utilize BCP’s Personalized Medicine Platform, powered by BC|GENOME, to implement end-to-end clinical NGS workflows for germline and somatic tumour testing, enabling data-driven personalized care for patients.
BC Platforms will provide its Discovery and Research Platform, BC|INSIGHT, for curating and analysing clinical and omics data in a secure format to enhance translational research capabilities. Bumrungrad will also become a BCP data partner, for which it will contribute valuable, diverse data samples for research.
Our investment in BC platforms was driven by the belief in their the technology and the means to federate clinical and genomic data.